XM does not provide services to residents of the United States of America.

Japan's Nikkei falls after sharp gains, central bank meetings in focus



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>REFILE-Japan's Nikkei falls after sharp gains, central bank meetings in focus</title></head><body>

Corrects Nikkei level in paragraph 2 to 38,101.24 from 38,10124

TOKYO, July 30 (Reuters) -Japan's Nikkei share average fell on Tuesday, as investors sold stocks after sharp gains in the previous session, while caution prevailed ahead of key central bank meetings in Japan and the United States.

The Nikkei .N225 fell 0.96% to 38,101.24by the midday break. The index rose 2% in the previous session, rebounding from a three-month low hit last week.

The broader Topix .TOPX fell 0.87% to 2,735.7.

"The Nikkei rose too much yesterday and the market did not find any reason to justify further gains today," said Jun Morita, general manager of the research department at Chibagin Asset Management.

"After all, the index came back to where it was before it started a rally to hit a record high earlier this month."

Markets are pricing almost no chance of a U.S. rate cut this week but have fully priced a 25 basis-point reduction for September.

The Bank of Japan is expected to announce quantitative tightening plans at this week's meeting and the market is divided about a rate hike.

Uniqlo-brand owner Fast Retailing 9983.T fell 2.19% to drag the Nikkei the most. Technology investor SoftBank Group 9984.T lost 2.06% and chip-equipment maker Tokyo Electron 8035.T slipped 1.64%.

Fanuc 6954.T jumped 3.26% to become the biggest support for the Nikkei after the robot maker raised its annual operating profit forecast by 0.8%.

Pasona Group 2168.T surged 13.4% after a regulatory filing showed activist investor Oasis Management owns 5.02% stake in the staffing and outsourcing company.

Of the 225 components of the Nikkei, 46 stocks rose and 175 fell, with three trading flat.



Reporting by Junko Fujita; Editing by Subhranshu Sahu

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.